Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Log in to your Inderes Free account to see all free content on this page.
Create account

Chr. Hansen Holding

Less than 1K followers
All
Press releases
ShowingAll content types
Regulatory press release1/29/2024, 10:26 AM

Completion of the combination between Novozymes and Chr. Hansen

Chr. Hansen Holding
Regulatory press release1/26/2024, 11:09 AM

All necessary regulatory approvals have been obtained for the combination of Novozymes and Chr. Hansen

Chr. Hansen Holding
Press release12/20/2023, 2:02 PM

Update on the merger approval process for the combination of Novozymes and Chr. Hansen: South Korean merger approval granted

Chr. Hansen Holding

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
Create account
Regulatory press release12/19/2023, 10:54 AM

Major shareholder announcement from Burlington Loan Management DAC

Chr. Hansen Holding
Press release12/12/2023, 4:11 PM

Update on the merger approval process for the combination of Novozymes and Chr. Hansen: Conditional competition clearance from the European Commission obtained

Chr. Hansen Holding
Regulatory press release11/20/2023, 7:03 AM

Update on the merger approval process for the combination of Novozymes and Chr. Hansen: The parties have submitted a remedy proposal to the European Commission.

Chr. Hansen Holding
Regulatory press release11/2/2023, 12:10 PM

Managers' Transaction

Chr. Hansen Holding
Regulatory press release10/13/2023, 1:15 PM

Managers' Transactions

Chr. Hansen Holding
Regulatory press release10/12/2023, 6:02 AM

Chr. Hansen Holding A/S Interim Report Q4 2022/23

Chr. Hansen Holding
Regulatory press release10/10/2023, 6:08 AM

Novozymes announce the Executive Leadership Team and organizational structure for the future combined company of Novozymes and Chr. Hansen

Chr. Hansen Holding
Regulatory press release9/27/2023, 7:23 AM

Major shareholder announcements from Burlington Loan Management DAC and Davidson Kempner Capital Management LP

Chr. Hansen Holding
Regulatory press release9/4/2023, 9:48 AM

Update on the combination of Novozymes and Chr. Hansen: Chinese merger approval granted, supporting the path to completion

Chr. Hansen Holding
Regulatory press release7/6/2023, 6:03 AM

Chr. Hansen Holding A/S Interim Report Q3 2022/23

Chr. Hansen Holding
Regulatory press release4/13/2023, 6:02 AM

Chr. Hansen Holding A/S Interim Report Q2 2022/23

Chr. Hansen Holding
Regulatory press release3/30/2023, 4:07 PM

Novozymes’ and Chr. Hansen’s shareholders approve combination to create a leading global biosolutions partner

Chr. Hansen Holding
Regulatory press release3/30/2023, 3:57 PM

Resolutions passed at the Extraordinary General Meeting of Chr. Hansen Holding A/S

Chr. Hansen Holding
Regulatory press release3/30/2023, 11:11 AM

Combination between Novozymes and Chr. Hansen approved by Novozymes’ shareholders

Chr. Hansen Holding
Regulatory press release3/28/2023, 10:07 AM

Update on the combination of Novozymes and Chr. Hansen: U.S. antitrust regulation waiting period has expired, supporting the path to completion

Chr. Hansen Holding
Regulatory press release3/8/2023, 7:05 AM

Notice to convene Extraordinary General Meeting

Chr. Hansen Holding
Regulatory press release3/8/2023, 7:00 AM

Publication of exemption document in relation to the proposed combination of Chr. Hansen and Novozymes, confirmation of outlook for 2022/23 and proposed candidates to the Board of Directors of the combined company

Chr. Hansen Holding
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.